Literature DB >> 15046728

Effects of cholinergic enhancement on visual stimulation, spatial attention, and spatial working memory.

P Bentley1, M Husain, R J Dolan.   

Abstract

We compared behavioral and neural effects of cholinergic enhancement between spatial attention, spatial working memory (WM), and visual control tasks, using fMRI and the anticholinesterase physostigmine. Physostigmine speeded responses nonselectively but increased accuracy selectively for attention. Physostigmine also decreased activations to visual stimulation across all tasks within primary visual cortex, increased extrastriate occipital cortex activation selectively during maintained attention and WM encoding, and decreased parietal activation selectively during maintained attention. Finally, lateralization of occipital activation as a function of the visual hemifield toward which attention or memory was directed was decreased under physostigmine. In the case of attention, this effect correlated strongly with a decrease in a behavioral measure of selective spatial processing. Our results suggest that, while cholinergic enhancement facilitates visual attention by increasing activity in extrastriate cortex generally, it accomplishes this in a manner that reduces expectation-driven selective biasing of extrastriate cortex.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15046728     DOI: 10.1016/s0896-6273(04)00145-x

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  63 in total

1.  Cholinergic modulation of hippocampal activity during episodic memory encoding in postmenopausal women: a pilot study.

Authors:  Julie A Dumas; Brenna C McDonald; Andrew J Saykin; Thomas W McAllister; Mary L Hynes; John D West; Paul A Newhouse
Journal:  Menopause       Date:  2010-07       Impact factor: 2.953

2.  Effects of cholinesterase inhibitor on brain activation in Alzheimer's patients measured with functional near-infrared spectroscopy.

Authors:  Florian G Metzger; Ann-Christine Ehlis; Florian B Haeussinger; Andreas J Fallgatter; Katja Hagen
Journal:  Psychopharmacology (Berl)       Date:  2015-09-11       Impact factor: 4.530

Review 3.  Orexin/hypocretin modulation of the basal forebrain cholinergic system: Role in attention.

Authors:  J Fadel; J A Burk
Journal:  Brain Res       Date:  2009-08-21       Impact factor: 3.252

4.  Prompt but inefficient: nicotine differentially modulates discrete components of attention.

Authors:  Signe Vangkilde; Claus Bundesen; Jennifer T Coull
Journal:  Psychopharmacology (Berl)       Date:  2011-06-01       Impact factor: 4.530

Review 5.  Cholinergic modulation of cognition: insights from human pharmacological functional neuroimaging.

Authors:  Paul Bentley; Jon Driver; Raymond J Dolan
Journal:  Prog Neurobiol       Date:  2011-06-17       Impact factor: 11.685

6.  Scopolamine impairs auditory delayed matching-to-sample performance in monkeys.

Authors:  Bethany Plakke; Chi-Wing Ng; Amy Poremba
Journal:  Neurosci Lett       Date:  2008-04-10       Impact factor: 3.046

7.  Rats and humans paying attention: cross-species task development for translational research.

Authors:  Elise Demeter; Martin Sarter; Cindy Lustig
Journal:  Neuropsychology       Date:  2008-11       Impact factor: 3.295

8.  Cholinergic enhancement reduces functional connectivity and BOLD variability in visual extrastriate cortex during selective attention.

Authors:  Emiliano Ricciardi; Giacomo Handjaras; Giulio Bernardi; Pietro Pietrini; Maura L Furey
Journal:  Neuropharmacology       Date:  2012-08-18       Impact factor: 5.250

9.  Cholinergic enhancement eliminates modulation of neural activity by task difficulty in the prefrontal cortex during working memory.

Authors:  Maura L Furey; Emiliano Ricciardi; Mark B Schapiro; Stanley I Rapoport; Pietro Pietrini
Journal:  J Cogn Neurosci       Date:  2008-07       Impact factor: 3.225

10.  New MRI Biomarkers Advance the Characterization of Parkinson Disease.

Authors:  David A Ziegler; Suzanne Corkin
Journal:  Eur Neurol Rev       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.